Skip to main content
Account Strategy

How Buying Signals Should Change Account Priority

Most target-account lists are snapshots. Buying signals reveal when a mediocre opportunity becomes one of the best accounts in the market.

By Stuart Tarnowski · Published · 8 min read

What is a buying signal in healthcare sales?

Most target-account lists are snapshots.

Markets are not.

A buying signal is an observable change inside an organization that should raise or lower its priority in your pipeline, even when nothing about the account's profile has changed.

A practice that was a mediocre opportunity three months ago may become one of the best accounts in the market tomorrow. Something changed. That change is a buying signal.

A useful buying signal is an observable event that changes the likelihood that an organization may have a need, budget, urgency, or reason to evaluate a solution.

The signal itself does not mean the organization will buy. It means the commercial context has changed.

What are examples of buying signals for healthcare companies?

The answer depends on what you sell.

  • For an RCM company: a new practice opening, new CFO or revenue-cycle leader, multiple billing or coding job openings, an acquisition or merger, rapid provider growth, a new procedural service line, an EHR or practice-management transition, increased prior-authorization complexity, or public signs of reimbursement and collections pressure.
  • For a CCM or RPM company: joining an ACO, CIN or value-based contract, expanding a Medicare population, hiring care-management or population-health staff, launching chronic-disease initiatives, adding locations or specialties with strong chronic-care populations, new population-health leadership, or a new focus on reducing readmissions and improving care gaps.
  • For a medical-device company: a physician joining who specializes in a relevant procedure, launch of a new surgical or procedural service line, expansion into a new ambulatory surgery center, increased procedure volumes, replacement-cycle timing, capital-budget approval, facility expansion, new clinical leadership, or adoption of a new clinical technique.
  • For an HR or workforce company: rapid provider or employee growth, multiple open clinical or administrative roles, opening new locations, high turnover, new HR leadership, acquisition or merger activity, centralization of HR across practices, movement to an MSO structure, expansion into multiple states, increased contract labor, or PE-backed growth pressuring professionalization of HR infrastructure.

Why can the same event mean different things to different companies?

The same event can mean different things to different companies. This is where signal intelligence becomes especially useful.

Suppose a multi-specialty group announces that it is opening three new locations. For an RCM company, that may indicate increased billing complexity. For an HR company, it may indicate recruiting, onboarding, payroll, benefits and workforce-management needs. For a medical-device company, the relevance may depend on whether those locations include procedure rooms or new specialists. For an RPM company, it may matter if the expansion includes a Medicare-heavy chronic-care population.

The event is the same. The commercial meaning is different.

Why should static account tiers become dynamic?

Imagine an account originally receives a moderate fit score. Then it hires a new operational executive, announces three locations, and begins recruiting aggressively. Its priority should change.

A modern commercial system should continuously evaluate: Account Fit × Buying Signals × Outreach Readiness.

High-fit organizations with strong signals and sufficient research should rise. Accounts with weak timing should fall. This is much more useful than assigning an account to Tier 1 in January and leaving it there for the rest of the year.

Why do signal clusters matter more than single signals?

Not all signals deserve the same weight.

A single job opening may be mildly interesting. Ten job openings combined with a new location and a new COO is different.

The strongest commercial intelligence often comes from signal clusters:

  • RCM: New CFO + six billing openings + EHR migration.
  • CCM/RPM: Joined an ACO + hired a Population Health Director + expanding Medicare PCP network.
  • Medical device: New procedural specialist + ASC expansion + new equipment-related hiring.
  • Healthcare HR: Three new locations + 40 open roles + newly hired HR executive.

How should buying signals trigger action?

The point of detecting a signal is not to create another dashboard. A useful signal should influence behavior.

That can mean researching the account, identifying the stakeholder, changing the message, moving the account into active outreach, calling instead of emailing, reconnecting with a previously dormant opportunity, or adding additional decision makers to the outreach.

A signal should answer a practical question: What should we do differently because this happened?

How should buying signals change account priority without changing strategy?

There is an important distinction. One signal can justify increasing the priority of an account. It usually should not cause a company to change its entire target market.

If a medical group announces a large hiring push, that may make it a stronger HR prospect. If several similar medical groups begin showing the same pattern—and those organizations consistently engage, buy and succeed as customers—that becomes evidence about the market itself.

The hierarchy matters: one signal changes an account's priority; repeated signals reveal a pattern; patterns combined with customer outcomes can influence market strategy.

What is the goal of better timing in provider outreach?

Many healthcare companies already know who their potential customers are. The harder question is: Which ones should we focus on right now?

Buying signals help answer that. They turn a static target list into a dynamic commercial system.

The difference between a cold account and a strong opportunity is often not who the organization is. It is what has changed.

Want our read on your market?

We are happy to share how we would approach the research before any engagement begins.